Data Collection on Adverse events of Anti-HIV Drugs (D:A:D)

Caroline Sabin, Andrew Phillips, David Kamara, Colette Smith

The Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) is a prospective multi-cohort study of HIV-infected persons under active follow up. The purpose of the study is to assess the incidence of cardiovascular disease among HIV/AIDS patients and to investigate whether treatment with antiretroviral drugs is associated with the development of this cardiovascular disease. The remit of the study has now broadened to include analyses of the incidence of several further serious non-AIDS events (liver and renal failure and malignancies). The study is coordinated by the Copenhagen HIV Program, headed by Prof Jens Lundgren (jdl@cphiv.dk) and all statistical support is provided from the Unit. Financial support for the study is provided by 'The Oversight Committee for The Evaluation of Metabolic Complications of HAART', to which a number of pharmaceutical companies producing antiretroviral drugs contribute financially. The D:A:D Study is now embarking in its 11th year and is projected to continue at least until 2012. Further details at www.cphiv.dk

Click here to go back to the list of studies in the HIV Epidemiology and Biostatistics Group

Page last modified on 02 dec 10 12:37